PALI·696389402·US·equity·Healthcare - Biotechnology-13D/G
PALI (PALISADE BIO INC) is held by 47 institutional investors as of Q1 2026. Largest holders: JANUS HENDERSON GROUP PLC ($18.8M), AMERIPRISE FINANCIAL INC ($15.2M), RA CAPITAL MANAGEMENT, L.P. ($12.5M). Net institutional sentiment: Mixed.
See how PALI's score breaks down across 4 SEC sources
Showing 1-20 of 56
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer